NCT01088412View on ClinicalTrials.gov

Observational Study of Somatropin Treatment in Children

CompletedOBSERVATIONAL
Enrollment

22,845

Participants

Timeline

Start Date

April 30, 1999

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Growth Hormone (GH) DeficiencyShort Stature Homeobox Containing Gene (SHOX) DeficiencySHOX Deficiency-related DisorderNon-GH-deficient Growth Disorders
Interventions
DRUG

Somatropin (recombinant deoxyribonucleic acid [rDNA] origin)

Dose, frequency and duration at discretion of attending physician.

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY